Member Info for Porter_

Sounds like the team will be super busy the next 2 weeks Money!

Great to see the share price moving in the right direction after a quiet few weeks :)

Thanks Money. Hoping my circumstances allow me to hold til the day the company is bought out. With so many high profile experts involved in the science and a route map that has never failed, I have great confidence in the company.

Also nice to see some bigger trades today and the share price moving UP!

Best thing you can do is hit that filter button Money. Life is so much better without trolls in it :)

I’m positive for what lays ahead too and the 3rd party updates look very promising.

I’ve enjoyed the time it’s taken for news, as have continued to passively load up. Still approx £5k under getting back to 1%, but more than happy with my current average and position.

Some background on 2Bridge:

https://www.labiotech.eu/partner/tiger-teams-transforming-life-sciences-startup-landscape/

https://2bridge.be/

Belgium based, experience with Pharma giants Johnson and Johnson, Galapagos and Argenix.

Simon Deré

From R&D discovery to early clinical development 💉Meet 2 Bridge Consultancy at 📍 Advanced Therapies📍Dutch Lifescience Conference 📍 BIOFIT 📍

1d

2 Bridge will be attending the Advanced Therapies in Belgium Event on October 15th 📍

Many therapies, especially those originating from academic research, often stumble when it comes to regulatory and CMC requirements. 👉 Let's connect and discuss how we can navigate these challenges together.

We’d love to grab a coffee ☕ and chat about how to successfully translate complex therapies into first-in-human clinical trials.

And don’t miss out—Dominique Van Looveren will be speaking about our work with Genflow Biosciences (LON:GENF) (OTCQB:GENFF).

Genflow Biosciences is a UK based biotech company with R&D facilities 🔬 in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans 🧔 and dogs 🐕 .

Stay tuned for more details on timing ⏲ !

Looking forward to seeing you there!

BioWin MEDVIA Normec

#AdvancedTherapies #ClinicalTrials #RegulatoryAffairs #CMC #2Bridge

https://www.linkedin.com/posts/simondere_advancedtherapies-clinicaltrials-regulatoryaffairs-activity-7248961507466579968-T8Q7?utm_source=share&utm_medium=member_ios

Money you have nothing to apologise for. It’s unfortunate there are bullies in the world who are clearly unhappy in their lives, but I appreciate your positivity and very well thought out research. Please keep it up :)

Have filtered them Money. We’re far too classy to give our time to trolls :)

It closed 52% up which is a fact.

We get that you’re a troll and live in a cave, but you don’t have to spend your day checking what we’re up to, go out and enjoy the sun, seems like you need some light in your life!

Beginning to sound like a paid deramper Lile…

OTC can be confusing as they trade very different to LSE.

Hopefully that share float on OTC will get blitzed money.

ATM I’d say the 2m shares have been added the float to create a market for when news does get going, as there was not sufficient stock available previously.

Just hope the UK market opens in alignment!

We’ve been patient the past 3 years, now it’s time for the fireworks to happen :)

Money, you checked OTC?

Out of hours trade took the share price up 52% and it is sitting at 0.32p.

Wonder if it will peg and impact the UK market on open tomorrow?

Yes good spot Money.

If they get the patents approved in one medical area, can their products be cross utilised across other patient conditions, without having to go through further clinical studies?

Has roach got water yet, or is he still cleaning the sludge by hand?

Another pharma company has just raised $400m for their development of weight loss drugs:

https://longevity.technology/news/kailera-emerges-with-400m-to-advance-next-generation-weight-loss-drugs/amp/

It’s also worth doing research on what SIRT6 does for weight loss and diabetes:

https://www.healthline.com/nutrition/sirtfood-diet#TOC_TITLE_HDR_6

Genflow MCAP £7m….(43x less than Kailera’s funding round)

Just watched the interview, great to see all 5 programmes are now back on, more grants in the pipeline and manufacturers already being consulted!

I would say that RNS was just housekeeping Money.

You’re right, the performance map is on schedule.

That closing line on dog trials gave me prickles, as we’re fully aware pet trials require a lot less regulation and Eric was confident in previous interviews end of 2024 he would have a partnership / license agreement in advanced stages, so I have faith all is still on target.

My understanding is all Genflow had to do was declare their lab partner to the FDA and they were happy to give authorisation to proceed with human trials, or did I read this wrong? Either way, they’ve had 3 months so hopefully both sides have had plenty of time to get everything in place and approved now :)

Is that 15% of the float that just got snapped up?

I really enjoyed watching todays presentation. I’m hoping that Eric’s right and ageing will officially be recognised as a disease and licensing or takeover could come sooner than we expect!

https://www.youtube.com/live/p9d8ABx8GoA?feature=shared

Everything happens for a reason Money. The presentation is 3pm tomorrow as on Eastern Time. Hopefully we’ll get some decent updates :)